Literature DB >> 21255221

Influenza A H1N1 in HIV-infected adults.

E Martínez1, M A Marcos, I Hoyo-Ulloa, A Antón, M Sánchez, A Vilella, M Larrousse, I Pérez, A Moreno, A Trilla, T Pumarola, J M Gatell.   

Abstract

OBJECTIVES: HIV-infected adults are considered to be at higher risk for influenza A H1N1 complications but data supporting this belief are lacking. We aimed to compare epidemiological data, clinical characteristics, and outcomes of influenza A H1N1 infection between HIV-infected and -uninfected adults.
METHODS: From 26 April to 6 December 2009, each adult presenting with acute respiratory illness at the emergency department of our institution was considered for an influenza A H1N1 diagnosis by specific multiplex real-time polymerase chain reaction. For every HIV-infected adult diagnosed, three consecutive adults not known to be HIV-infected diagnosed in the same calendar week were randomly chosen as controls.
RESULTS: Among 2106 adults tested, 623 (30%) had influenza A H1N1 infection confirmed. Fifty-six (9%) were HIV-positive and were compared with 168 HIV-negative controls. Relative to HIV-negative controls, HIV-positive patients were older, more frequently male, and more frequently smokers (P≤0.02). In the HIV-positive group, prior or current AIDS-defining events were reported for 30% of patients, 9% and 30% had CD4 counts of <200 and 200-500cells/μL, respectively, and 95% had HIV-1 RNA <50copies/mL. Pneumonia (9%vs. 25%, respectively, in the HIV-positive and HIV-negative groups; P=0.01) and respiratory failure (9%vs. 21%, respectively; P=0.04) were less common in the HIV-positive group. Oseltamivir (95%vs. 71% in the HIV-positive and HIV-negative groups, respectively; P=0.003) was administered more often in HIV-positive patients. Three patients (all HIV-negative) died. In the HIV-positive group, CD4 cell count and plasma HIV-1 RNA did not differ before and 4-6 weeks after influenza A H1N1 diagnosis (P>0.05).
CONCLUSIONS: HIV infection did not increase the severity of influenza A H1N1 infection, and influenza A H1N1 infection did not have a major effect on HIV infection.
© 2011 British HIV Association.

Entities:  

Mesh:

Year:  2011        PMID: 21255221     DOI: 10.1111/j.1468-1293.2010.00905.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  11 in total

Review 1.  Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.

Authors:  Anandi N Sheth; Pragna Patel; Philip J Peters
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

2.  Discovery of anti-influenza nucleoside triphosphates targeting the catalytic site of A/PR/8/34/H1N1 polymerase.

Authors:  Nataraj Sekhar Pagadala; Rakesh Bhat; Jagadeesh Kumar D; Abdolamir Landi
Journal:  Med Chem Res       Date:  2020-05-24       Impact factor: 1.965

Review 3.  Host genetics of severe influenza: from mouse Mx1 to human IRF7.

Authors:  Michael J Ciancanelli; Laurent Abel; Shen-Ying Zhang; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2016-01-04       Impact factor: 7.486

Review 4.  Treating HIV-Positive/Non-AIDS Patients for Community-Acquired Pneumonia with ART.

Authors:  Catia Cillóniz; Antonella Ielpo; Antoni Torres
Journal:  Curr Infect Dis Rep       Date:  2018-09-10       Impact factor: 3.725

5.  Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine.

Authors:  Adriana Weinberg; Petronella Muresan; Kelly M Richardson; Terence Fenton; Teresa Dominguez; Anthony Bloom; D Heather Watts; Mark J Abzug; Sharon A Nachman; Myron J Levin
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.

Authors:  Claire-Anne Siegrist; Christian van Delden; Michael Bel; Christophe Combescure; Cécile Delhumeau; Matthias Cavassini; Olivier Clerc; Sara Meier; Karine Hadaya; Paola M Soccal; Sabine Yerly; Laurent Kaiser; Bernard Hirschel; Alexandra Calmy
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

7.  HIV-1 and its gp120 inhibits the influenza A(H1N1)pdm09 life cycle in an IFITM3-dependent fashion.

Authors:  Milene Mesquita; Natalia Fintelman-Rodrigues; Carolina Q Sacramento; Juliana L Abrantes; Eduardo Costa; Jairo R Temerozo; Marilda M Siqueira; Dumith Chequer Bou-Habib; Thiago Moreno L Souza
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

8.  HIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected children.

Authors:  Timothy R Leahy; Michelle Goode; Paul Lynam; Patrick J Gavin; Karina M Butler
Journal:  Influenza Other Respir Viruses       Date:  2014-02-18       Impact factor: 4.380

9.  Pandemic Influenza A (H1N1) Virus Infection Increases Apoptosis and HIV-1 Replication in HIV-1 Infected Jurkat Cells.

Authors:  Xue Wang; Jiying Tan; Santanu Biswas; Jiangqin Zhao; Krishnakumar Devadas; Zhiping Ye; Indira Hewlett
Journal:  Viruses       Date:  2016-02-02       Impact factor: 5.048

10.  Etiology, clinical, and epidemiological characteristics of severe respiratory infection in people living with HIV.

Authors:  A C Pecego; R T Amâncio; D M Costa; F A Bozza; M M Siqueira; M L Oliveira; J Cerbino-Neto; A Japiassu
Journal:  Int J STD AIDS       Date:  2020-01-22       Impact factor: 1.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.